Salarius Pharmaceuticals
SLRX
SLRX
14 hedge funds and large institutions have $321K invested in Salarius Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Two Sigma Investments
New York
|
$0 |
2 |
2
UBS Group
Zurich,
Switzerland
|
$116 |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$22.3K |
4 |
![]()
4
Fidelity Investments
Boston,
Massachusetts
|
$1 |